Exploring groundbreaking patents and therapies targeting the p53 protein to revolutionize cancer treatment.
Discover how a 13-gene signature predicts response to MDM2 inhibitors in p53 wild-type cancers, enabling personalized therapy approaches.
Exploring how ribosomal protein S27a regulates p53's tumor suppression activities and its dual role in cancer progression.